View in EDS

MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.

Saved in:
Bibliographic Details
Title: MAGE-A3 as a target for cancer immunotherapy: A systematic review of clinical and preclinical evidence.
Authors: Telang G; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: gaurangtelang98@gmail.com., Mishra S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: smritimishra44@gmail.com., Sureshbabu A; School of Bioengineering, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu 600073, India. Electronic address: anuragsureshbabu@gmail.com., Kulkarni S; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: samkul1823@gmail.com., Joshi S; Acuere Biosciences Pvt. Ltd., Pune, Maharashtra 411043, India. Electronic address: drjoshisr@gmail.com., Singh R; Amity Institute of Biotechnology, Amity University Mumbai, Maharashtra, India. Electronic address: rsingh1@mum.amity.edu.
Source: Current problems in cancer [Curr Probl Cancer] 2025 Oct; Vol. 58, pp. 101237. Date of Electronic Publication: 2025 Jul 30.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-6345
DOI:10.1016/j.currproblcancer.2025.101237